Our Charter highlights the Alliance’s policy statements to drive united heart health action in the Asia-Pacific.
Estimated direct and indirect costs of CVD amounts to US$46.3 billion and 0.9% of GDP in just seven Asian health systems alone (Australia, China, Japan, Singapore, South Korea, Taiwan, Thailand).
Many people with CVD rely on informal caregivers, but they too suffer from distressing physical, emotional and economic effects which affects their mental health and quality of life. Several studies have shown that caregivers may feel more social isolation as they replace social activities with caregiving responsibilities.
Recognising these challenges, united multisectoral action to combat CVD is needed in a diverse Asia-Pacific. The Asia-Pacific Cardiovascular Disease Alliance’s goal is to improve heart health and reduce death and disabilities from heart attacks and strokes.
The Alliance aims to do so by uniting action around improving patient advocacy; raising public and policy awareness for CVD to ultimately to increase resourcing for CVD innovations (policies, care models, products or services).
by prioritising low-resource settings and underserved populations across low, middle and high-income health systems across the Asia-Pacific. Universal health coverage and access to CVD services should also be emphasised as the building blocks of an effective health system.
across the life-course and care continuum. Recognise that patients have multiple comorbidities including CVD, diabetes, CKD and lipid disorders which necessitates a holistic approach to tackle CVD including from actors outside public health. A broader view of CVD is required comprising other determinants of health including social, environmental, cultural, structural, economic and commercial factors.
in developing context-specific solutions and findings for CVD action across the Asia-Pacific.
across disciplines, specialties, and sectors to create innovative solutions, public awareness, and policy change. A whole-of-government and whole-of-society approach is required to tackle these challenges.
The Alliance calls on all Asia-Pacific health systems to focus on the following in designing united CVD action.
Recognising that the root causes of CVD stem from wider determinants of health in society, health systems should aim to:
Health systems should detect and better manage high-risk CVD patients, including with the following modifiable risk factors:
Lower the risk of an additional event occurring.
Early detection of high-risk CVD patients can save lives and reduce hospital admissions. This lowers the burden on health systems in high-income and low and middle-income countries. Asia-Pacific health systems should aim to:
Asia-Pacific health systems should be equipped to manage acute CVD events as follows:
Rehabilitation helps prevent recurrence, improves functional capacity, recovery, and psychological well-being. It allows patients to return to an optimal quality of life. Asia-Pacific health systems should increase the number of cardiac patients participating in rehabilitation as follows:
Improving cardiovascular health in the Asia-Pacific can significantly improve the quality of life for individuals, future-proof health systems, and foster wellbeing and economic prosperity.